Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04161157 · ClinicalTrials.gov registry record · NA
Piloting Pathways With Lung Cancer Patients
A NA study, sponsored by Laurie McLouth.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT04161157: Completed NA study, sponsored by Laurie McLouth.
NCT04161157 is a NA study that has completed, run by Laurie McLouth. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04161157, a NA study, has completed, sponsored by Laurie McLouth.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this research is to determine the feasibility of a new supportive intervention, called Pathways, for patients with advanced stage and metastatic lung cancer.
Interventions
- BEHAVIORAL Pathways
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2020-01-13 |
| Est. Completion | 2022-08-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04161157
The ClinicalTrials.gov registry entry for NCT04161157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Laurie McLouth, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pathways is the first listed.
NCT04161157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04161157 about?
NCT04161157 is a clinical study titled "Piloting Pathways With Lung Cancer Patients". The purpose of this research is to determine the feasibility of a new supportive intervention, called Pathways, for patients with advanced stage and metastatic lung cancer.
What is the current status of trial NCT04161157?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2020-01-13. Estimated completion is 2022-08-03.
What interventions are being tested in trial NCT04161157?
The interventions under investigation include: Pathways (BEHAVIORAL).
Who is sponsoring clinical trial NCT04161157?
This trial is sponsored by Laurie McLouth, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.